Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

 

Join us for the IDEU Symposium 2026, a dynamic two-day event showcasing world-leading research in infectious disease epidemiology and global health. Taking place at the Richard Doll Lecture Theatre, the symposium will bring together internationally renowned speakers, early- and mid-career researchers, and partners from across academia, healthcare, and industry.

The programme features cutting-edge talks on antimicrobial resistance, HIV, vaccines, bioengineering, mathematical modelling, and global health ethics, alongside panel discussions, poster sessions, and dedicated sessions highlighting emerging research talent within IDEU. With ample opportunities for networking and collaboration, the IDEU Symposium offers a vibrant forum to exchange ideas, spark new partnerships, and shape the future of infectious disease research.

Registration closes on Tuesday 24th February. 

View the programme [PDF].

 

Meeting programme:

WEDNESDAY 4 MARCH

Time        Speaker and title
9:30-10:00        Registration and coffee
Session 1 Chair: Angela Brueggemann
10:00-10:15

Welcome and introduction to the IDEU:
Angela Brueggemann, IDEU Director

10:15-10:35

Odile Harrison: Neisseria meningitidis carriage, antimicrobial resistance and risk factors in UK men who have sex with men

10:35-10:55 Danny Wilson: Linking UK Biobank to UKHSA data to find infection causes
10:55-11:15 Leon Peto: The RECOVERY platform trial: present and future
11:15-11:45 Tea, coffee, networking
Session 2 Chair: Helen Fryer
11:45-12:05

Melissa Iacovidou and Dr Phyllis Munyiva, on behalf of Professor Goylette Chami: SchistoTrack: A prospective, community-based cohort focused on intestinal schistosomiasis in Uganda

12:05-12:25 Joris Hemelaar: The unfinished business of the HIV pandemic
12:25-12:45

Molly Stevens: Developing and translating bioengineering technologies for better health

12:45-14:00 Lunch, networking
Session 3 Chair: Ana Unitt and Matt Quinn
14:00-15:00

IDEU early- and mid-career researcher 5-minute talks

Shing Zhan: Towards scalable inference of ancestral recombination graphs for bacteria 

Iman Yassine: Longitudinal population dynamics of Moraxella catarrhalis in the nasopharynx during the first year of life 

Saskia Proud: Exploring phage diversity in Haemophilus influenzae 

Hugh White: Evidence of human-pathogen genetic interactions in Staphylococcus aureus bloodstream infections 

Helen Fryer: Big data methods for identifying non-genetic risk factors for microbial disease

Vanessa Tobert: The role of antibody and antigen status as biomarkers for the use of neutralising antibody therapies: analysis of 21,446 participants in the RECOVERY trial

Alyssa Fitzpatrick: Adverse maternal outcomes in women living with HIV: a systematic review and meta-analysis

Ayisha Khalid: Global and regional molecular epidemiology of HIV-1 during 1990-2024

 

Q & A (10 minutes)

15:00-15:30 Tea, coffee, networking
Session 4 Chair: Prabhat Jha
15:30-15:50

Robin Thompson: Mathematical modelling at the end of an infectious disease outbreak

15:50-16:10                   Nicole Stoesser: The link’s the sink! Sinks and Gram-negative pathogens in healthcare settings
16:10-16:30 Simon Draper: Advances in vaccines and antibodies for blood-stage malaria
16:30-16:50 Caeser Atuire: Health research partnerships in a fragmenting world order
17:00-19:00           

Drinks reception in the Richard Doll Building

THURSDAY 5 MARCH

Time Title
9:30-10:00    Registration and coffee
Session 5 Chair: Helen Fryer
10:00-10:20

Adrian Smith: Responding to HIV epidemics among sexual and gender minorities: live
and let DEI?

10:20-10:40

Angela Brueggemann: The IRIS Consortium reveals significant changes in invasive
bacterial disease as a result of the COVID-19 pandemic

10:40-11:00

Mike Parker: The Global Health Bioethics Network: a collaborative network designed
to identify and address ethical issues in research

11:00-11:30 Tea, coffee, networking
Session 6 Chairs: Iman Yassine and Melissa Iacovidou
11:30-12:35

IDEU early- and mid-career researcher five-minute talks plus Q&A

Ana Unitt: A core genome approach to exploring antimicrobial resistance in Neisseria gonorrhoeae

Krisna Made: Predicting azithromycin resistance in Neisseria gonorrhoeae using machine learning 

Matt Quinn: Assessing the impact of the UK RSV vaccination programme on antibiotic usage and antimicrobial resistance 

Priya Lall: Assessment of the feasibility of a One Health surveillance system

Sandrena Frischer : Referrals in the absence of clinical management guidance: navigating continuity of care for participants in a longitudinal study on chronic schistosomiasis infection in rural Uganda

Max Lang: Malaria-Schistosoma mansoni co-infection in Ugandan fishing communities 

Eloise Ockenden: Clinical decision support systems for periportal fibrosis staging 

Zizheng Zhang: Last observations of inpatient physiology data are more effective than time series in mortality prediction 

Kieran Johnstone: Harm from bloodstream infections in acute and emergency care 

Q & A (10 minutes)

12:35 - 13:35                       Lunch, networking, posters
Session 7 Chair: Adrian Smith and Leon Peto
13:35-13:55 Gil McVean: The Pathogen Project at EIT
13:55-14:15

Susanne Hodgson: Human challenge studies to accelerate gonorrhoea vaccine
development

14:15-15:15

Panel discussion: 

Open data in the age of digital epidemiology: benefits, risks, and responsibilities. Should open data be the default in infectious disease research? The panel members and audience will discuss the opportunities and challenges associated with open data

Panel: Gil McVean, Ben Lacey, Odile Harrison, Joris Hemelaar, Angeliki Kerasidou

Session 8 Chair: Angela Brueggemann
15:20-15:40 Industry sponsor
15:40-16:00 Industry sponsor
16:00-16:15  Closing remarks: Angela Brueggemann

Sponsors:

 

 

Forthcoming events

The cause(s) of autism spectrum disorder

Tuesday, 24 February 2026, 1pm to 2pm @ Richard Doll Building, Lecture Theatre

Mortality impacts of rainfall and sea level rise

Tuesday, 10 March 2026, 1pm to 2pm @ Richard Doll Building, Lecture Theatre

Festival of Global Health – 2040

Wednesday, 11 March 2026, 4pm to 8pm @ Curzon Oxford, Westgate Shopping Centre, Oxford OX1 1NZ